We are live on ! Find out more
PCM

Polaris Capital Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 40.82%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+40.82%
3 Year Est. Return
+94.3%
5 Year Est. Return
+113.49%
10 Year Est. Return
+358.47%
AUM
$3.1B
AUM Growth
+$51.4M
Cap. Flow
+$102M
Cap. Flow %
3.28%
Top 10 Hldgs %
48.78%
Holding
106
New
4
Increased
29
Reduced
19
Closed
3

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$224M
2
NEE icon
NextEra Energy
NEE
+$1.22M
3
MTB icon
M&T Bank
MTB
+$1.11M
4
SUPN icon
Supernus Pharmaceuticals
SUPN
+$1.01M
5
ALE
Allete
ALE
+$989K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$52.7M
2
DGX icon
Quest Diagnostics
DGX
+$44.3M
3
BPOP icon
Popular Inc
BPOP
+$18.6M
4
INFY icon
Infosys
INFY
+$13.8M
5
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$1.93M

Sector Composition

Rank Sector Weight
1 Financials 27.15%
2 Healthcare 18.38%
3 Technology 13.56%
4 Consumer Staples 10.23%
5 Consumer Discretionary 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTUS
76
DELISTED
Natus Medical Inc
NTUS
$1.2M 0.04%
46,220
– –
BGSF icon
77
BGSF Inc
BGSF
$60M
$1.18M 0.04%
95,516
– –
CVI icon
78
CVR Energy
CVI
$3.13B
$1.16M 0.04%
64,300
– –
CPF icon
79
Central Pacific Financial
CPF
$1B
$1.14M 0.04%
43,583
– –
KNX icon
80
Knight Transportation
KNX
$11.4B
$1.11M 0.04%
24,494
– –
CENTA icon
81
Central Garden & Pet Co Class A
CENTA
$2.44B
$1.1M 0.04%
28,500
– –
AMWD
82
DELISTED
American Woodmark
AMWD
$1.07M 0.03%
13,100
+3,500
+36% +$327K
CBT icon
83
Cabot Corp
CBT
$4.52B
$1.04M 0.03%
18,273
– –
SUPN icon
84
Supernus Pharmaceuticals
SUPN
$2.77B
$1.01M 0.03%
+32,900
New +$1.01M
TBRG
85
DELISTED
TruBridge
TBRG
$985K 0.03%
29,650
– –
ACIC icon
86
American Coastal Insurance
ACIC
$493M
$979K 0.03%
171,712
– –
SMP icon
87
Standard Motor Products
SMP
$911M
$949K 0.03%
21,900
– –
SGC icon
88
Superior Group of Companies
SGC
$225M
$947K 0.03%
39,600
– –
JOUT icon
89
Johnson Outdoors
JOUT
$505M
$932K 0.03%
7,700
-2,700
-26% -$362K
AIT icon
90
Applied Industrial Technologies
AIT
$13.3B
$929K 0.03%
10,200
-6,500
-39% -$620K
RRX icon
91
Regal Rexnord
RRX
$11.9B
$920K 0.03%
6,889
– –
HRMY icon
92
Harmony Biosciences
HRMY
$2.24B
$872K 0.03%
+30,900
New +$927K
LCII icon
93
LCI Industries
LCII
$2.65B
$762K 0.02%
5,800
– –
INDB icon
94
Independent Bank
INDB
$3.97B
$577K 0.02%
7,639
– –
EEFT icon
95
Euronet Worldwide
EEFT
$2.7B
$474K 0.02%
3,500
– –
BAP icon
96
Credicorp
BAP
$30.7B
$375K 0.01%
3,100
– –
CHCO icon
97
City Holding Co
CHCO
$2.04B
$316K 0.01%
4,195
– –
FSEA icon
98
First Seacoast Bancorp
FSEA
$80.3M
$147K ﹤0.01%
12,537
– –
DK icon
99
Delek US
DK
$3.58B
$146K ﹤0.01%
+6,741
New +$152K
NVS icon
100
Novartis
NVS
$297B
$46K ﹤0.01%
500
– –
1 2 3
4
5

Similar funds

BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
EC
E20 Capital Hong Kong $1.07B AUM
ZIG
Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
PP
Passaic Partners Newark, New Jersey $1.07B AUM 16.56% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Polaris Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Polaris Capital Management held 106 positions worth $3.1B, up 1.7% from $3.05B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Polaris Capital Management deployed $102M of net new capital in Q2 2021, opening 4 new positions and adding to 29 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 1,292,760 shares worth $230M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Quest Diagnostics, an estimated $44.3M trimmed.

  • Polaris Capital Management's largest Q2 2021 buy was Jazz Pharmaceuticals: 1,292,760 shares worth $230M.
  • Polaris Capital Management added most to NextEra Energy in Q2 2021, an estimated $1.22M increase.
  • Polaris Capital Management's biggest Q2 2021 reduction was Quest Diagnostics, cutting an estimated $44.3M.
  • Polaris Capital Management fully exited Alexion Pharmaceuticals in Q2 2021, selling an estimated $52.7M.
  • Polaris Capital Management's ten largest holdings make up 49% of its $3.1B portfolio in Q2 2021.
  • Polaris Capital Management opened 4 new positions and closed 3 in Q2 2021.
  • Polaris Capital Management's portfolio value rose 1.7% quarter-over-quarter to $3.1B.

Based on Polaris Capital Management's 13F filing for Q2 2021, filed 10 Aug 2021.